Activity

AI, In The World’s First, Has Developed A Drug, DSP-1181, Which May Treat Patients With Obsessive-Compulsive Disorder. DSP-1181 Is Now At Phase 1 Clinical Trials After 12 Months (Takes ~5 Years From Synthesizing A Drug To Trials). This’s Cool As AI, In The Future, May Make Drug Development Faster, Cheaper And More Efficient.

For The First Time Ever, A Drug Developed By AI Will Be Tested In Human Trials

https://www.forbes.com/sites/danadovey/2020/02/11/first-time-ever-artificial-intelligence-develops-drug-candidate/#784c03aa60de

In the case of developing drugs, while DSP-1181 may have been the first, scientists are convinced it is far from the last.